Experiment 417706

Worktypes

PHARMACOLOGY OF COMPOUND - IN HUMANSPATENT DESCRIBED

Compounds isolated

SENNOSIDE ASENNIDIN ASENNOSIDE BGALLIC ACID

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTIATHEROSCLEROTIC ACTIVITY
Administration routeORAL
OrganismEmpty organism
CitationMIZUGAKI,M: SATO,H: WAKITA,H: HIRAYAMA,H:. (1991). CHEMILUMINESCENCE INHIBITORS RHUBARB ANTHRAQUINONES.. ()
Amount utilized
Compound isolated
Dose amount10.0 MG
Number3
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitTABLET
Dose expressionDOSE